Clinical decision support software for breast cancer risk assessment to expand your comprehensive breast health services.
The product assigns a risk rating to a patient to drive a digital personalized screening plan for more consistent follow-up recommendations and more accurate diagnosis. This approach helps to catch cancers in the women that are at the greatest risk.
WRRisk simplifies breast risk program maintenance by eliminating paper and automating many of the manual steps, from collecting forms to letter generation.
The product equips patients and providers with the information they need. WRRisk Calculates 10-year and lifetime risk as well as risk-based on runner-up density.
WRRisk is built on top of existing well-established models for breast cancer risk.
Find out how our products can help your business increase compliance, increase revenue and improve outcomes.
1 Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K, for the Breast Cancer Surveillance Consortium. Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer. JAMA Oncol. 2017;3(9):1228–1236.